PB1980: ASC4KIDS: A MULTICENTER, OPEN-LABEL, PHASE 1B/2 STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

Hijiya, N., Kapoor, S., Hoch, M., Descamps, L., Dasgupta, K., & Cardoso, A. P. T. (2023). PB1980: ASC4KIDS: A MULTICENTER, OPEN-LABEL, PHASE 1B/2 STUDY TO DETERMINE THE DOSE AND SAFETY OF ASCIMINIB IN PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE. HemaSphere, 7(S3), e1669755. https://doi.org/10.1097/01.hs9.0000974736.16697.55
Authors:
Nobuko Hijiya
S. S. Kapoor
Matthias Hoch
Laurence Descamps
Kohinoor Dasgupta
Ana Paula Torres Cardoso
Affiliated Authors:
Nobuko Hijiya
Columbia Affiliation:
Subjects:
Efficacy and Resistance in CML Treatment (OpenAlex Topic)
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Developmental Pharmacology in Pediatric Drug Use (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1097/01.hs9.0000974736.16697.55
DOI:
10.1097/01.hs9.0000974736.16697.55
Journal:
HemaSphere
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: